S421-0326 Screening compound: N-cyclopropyl-2-{1-[(1-ethyl-1H-pyrazol-3-yl)carbonyl]tetrahydro-1H-pyrrol-3-yl}acetamide

S421-0326 Screening compound: N-cyclopropyl-2-{1-[(1-ethyl-1H-pyrazol-3-yl)carbonyl]tetrahydro-1H-pyrrol-3-yl}acetamide
S421-0326 Screening compound: N-cyclopropyl-2-{1-[(1-ethyl-1H-pyrazol-3-yl)carbonyl]tetrahydro-1H-pyrrol-3-yl}acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound S421-0326
N-cyclopropyl-2-{1-[(1-ethyl-1H-pyrazol-3-yl)carbonyl]tetrahydro-1H-pyrrol-3-yl}acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

S421-0326

Molecular Formula

C15H22N4O2 (C15 H22 N4 O2)

Compound Name

N-cyclopropyl-2-{1-[(1-ethyl-1H-pyrazol-3-yl)carbonyl]tetrahydro-1H-pyrrol-3-yl}acetamide

IUPAC name

N-cyclopropyl-2-[1-(1-ethyl-1H-pyrazole-3-carbonyl)pyrrolidin-3-yl]acetamide

SMILES

CCn(cc1)nc1C(N1CC(CC(NC2CC2)=O)CC1)=O

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

290.37

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

0.589

Distribution Coefficient, logD

0.589

Water Solubility, LogSw

-1.82

Polar Surface Area

55.827

Acid Dissociation Constant (pKa)

13.46

Base Dissociation Constant (pKb)

3.92

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

66.67

S421-0326 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

Bcl2-PPI Inhibitors Library (12246 compounds)

GPCR Targeted Library (31838 compounds)

Protein-Protein Interaction Library (218420 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Hemic and lymphatic
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
Mechanism of action:
  • PPI modulators
  • Receptor's ligands
  • PPI modulators
Targets:
  • GPCR
Structure:
  • Cyclic compounds

References: we are preparing a list of scientific research reports with S421-0326 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound S421-0326?
Check Price and Availability of S421-0326, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of S421-0326 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for S421-0326
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for S421-0326
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of S421-0326 available by request